Vasodilator Agents: Clinical Trials

3 trials of Vasodilator Agents, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 recruiting. 3 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 43Completed 2, Recruiting 1

Follow Vasodilator Agents: new trials by email Literature Review of Vasodilator Agents trials Research Report on Vasodilator Agents

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Sodium-glucose Cotransporter Type 2 Inhibitors for Acute Cardiorenal Syndrome Prevention
Standard list of drugs used for acute decompensation of CHF (loop diuretics, vasodilators, digoxin, inotropic agents, vasopressors), plus dapagliflozin (Forxiga; MP-002596) - Congestive Heart Failure
Phase 4CompletedI.M. Sechenov First Moscow State Medical University3702021-01-012022-12-07
Safety and Efficacy of ARNI After LVAD ImplanT (SEAL-IT) Study
Sacubitril-Valsartan, Usual care (standard-of-care) arm - Stage D Heart Failure
Phase 4RecruitingThe Cleveland Clinic502019-11-082021-06-07
Effect of Pioglitazone on Insulin Resistance, Atherosclerosis Progression and Clinical Course of Coronary Heart Disease
Pioglitazone 15 mg Tablet, Isosorbide Dinitrate 10Mg Tablet, Acetylsalicylic Acid 75Mg Tablet - Adverse Effect, Atherosclerosis, Coronary
Phase 4CompletedUkrainian Medical Stomatological Academy432012-11-012022-03-10

Conditions studied

Heart Failure (2)  ·  Atherosclerosis (1)  ·  Coronary Artery Disease (1)  ·  Coronary Disease (1)  ·  Insulin Resistance (1)  ·  Metabolic Syndrome (1)

Sponsors

I.M. Sechenov First Moscow State Medical University (1)  ·  The Cleveland Clinic (1)  ·  Ukrainian Medical Stomatological Academy (1)

Countries

Russia (1)  ·  Ukraine (1)  ·  United States (1)

Top investigators

Jerry D Estep, MD (1)